Design, implementation, and monitoring of HIV service packages for people who inject drugs: An assessment of programs supported by the Global Fund in 46 countries

• Published in: The International journal of drug policy 2021-02, Vol.88, p.103036-103036, Article 103036
• Main Authors: Burrows, Dave, Falkenberry, Haley, McCallum, Lou, Parsons, Danielle, Ngoksin, Ed, Zhao, Jinkou, Kunii, Osamu
• Format: Article
• Language: English
• Subjects: Drug policy; Drug use; Drugs; Exchange programs; HIV; HIV prevention; HIV treatment; Human immunodeficiency virus; International organizations; Interviews; Medical treatment; Mixed methods research; Opioids; Package design; People who inject drugs; Prevention; Prevention programs; Preventive medicine; Public health; Public policy; Services
• ISSN: 0955-3959; 1873-4758
• DOI: 10.1016/j.drugpo.2020.103036

People who inject drugs (PWID) are at higher risk of acquiring and transmitting HIV, accounting for an estimated 10% of HIV new infections globally. The World Health Organization (WHO) and other international agencies have clearly outlined the comprehensive package of services that should be available for PWID. This paper summarizes the data and findings from the PWID service packages assessed in 15 countries across different regions. It also provides data on the design of PWID programs in a further 30 countries that identified PWID as a key population in their national HIV strategic documents. A mixed-method approach was used, including desk reviews, key informant interviews, site observations and group interviews with implementers and PWID focus groups. Design of service packages varied considerably between countries while many matched the WHO Comprehensive Package. Only 85% countries (39/46) included needle-syringe exchange programs (NSEP) and 76% included opioid agonist therapy (OAT). Only 17% countries included overdose management in their package design. Across the 46 countries assessed, the average coverage with defined prevention package was 40% among countries for which coverage figures could be derived. Despite some examples of client-based, high-quality services in challenging environments, few countries, which rely primarily on external donor support, are reaching the necessary coverage levels across the full range of PWID HIV prevention, testing and care services. Transition from donor to domestic funding to fund this element of the HIV responses in many countries presents a compelling case to prevent PWID from being further left behind.